How do you get your company ready for venture funding? What internal due diligence steps do you need to take? Bringing together both company and venture perspectives, this panel will discuss the challenges of raising a venture equity round, as well as offering advice on due diligence issues ranging from IP to product development to the venture fundraising process.
Key areas to be covered include:
-
What are the three things that every executive summary must have in order to get VC interest?
-
The three most common questions that VCs will ask in a meeting that you better be ready to answer
-
How important is the management team early in the development cycle of the company and what are the “must have” positions?
-
How important is spending on IP, freedom to operate, and picket fence when you are pre-funded and have limited resources?
-
How important is a warm introduction
-
What are the alternatives to Sand Hill Road?
Panelists include: Avi Kulkarni, COO, Aviir; Antoun Nabhan, CFO, Presidio Pharma; Principal, Sagamore BioVentures; Jonathan Norris, Managing Director, Private Equity Group, SVB Capital; and Diana Villegas, CEO, Alpha Orthopaedics.
Related Insights
23 December 2024
Labor & Employment Law Perspectives
Regulating Artificial Intelligence in Employment Decision-Making: What’s on the Horizon for 2025
Share on TwitterShare by EmailShareBack to topEmployment law in 2024 could aptly be summarized as the “Year of Artificial Intelligence Legislation.
23 December 2024
Injunction Stayed: Corporate Transparency Act Enforcement Resumes
The U.S. Department of Justice scored a victory in ongoing litigation over the constitutionality of the Corporate Transparency Act (CTA) when the Fifth Circuit Court of Appeals stayed the nationwide preliminary injunction issued earlier this month by a federal district court in Texas.
23 December 2024
Health Care Law Today
Medicare Telehealth Flexibilities Get a Three-Month Lifeline
Share on TwitterShare by EmailShareBack to topAfter much uncertainty, Congress has extended many Medicare telehealth flexibilities through March 31, 2025, in its end-of-year appropriations bill.